"Glucagon" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511)
| Descriptor ID |
D005934
|
| MeSH Number(s) |
D06.472.699.587.469.500 D12.644.548.586.469.500
|
| Concept/Terms |
Glucagon- Glucagon
- Proglucagon (33-61)
- HG-Factor
- HG Factor
- Hyperglycemic-Glycogenolytic Factor
- Hyperglycemic Glycogenolytic Factor
- Glucagon (1-29)
- Glukagon
|
Below are MeSH descriptors whose meaning is more general than "Glucagon".
Below are MeSH descriptors whose meaning is more specific than "Glucagon".
This graph shows the total number of publications written about "Glucagon" by people in this website by year, and whether "Glucagon" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glucagon" by people in Profiles.
-
Tchio C, Baba K, Piccione G, Tosini G. Removal of melatonin receptor type 1 signalling induces dyslipidaemia and hormonal changes in mice subjected to environmental circadian disruption. Endocrinol Diabetes Metab. 2021 01; 4(1):e00171.
-
Karra S, Griffith WP, Kennedy RT, Gorski W. Hormone glucagon: electrooxidation and determination at carbon nanotubes. Analyst. 2016 Apr 21; 141(8):2405-11.
-
Gorton LM, Khan AM, Bohland M, Sanchez-Watts G, Donovan CM, Watts AG. A role for the forebrain in mediating time-of-day differences in glucocorticoid counterregulatory responses to hypoglycemia in rats. Endocrinology. 2007 Dec; 148(12):6026-39.
-
McGirr R, Ejbick CE, Carter DE, Andrews JD, Nie Y, Friedman TC, Dhanvantari S. Glucose dependence of the regulated secretory pathway in alphaTC1-6 cells. Endocrinology. 2005 Oct; 146(10):4514-23.
-
Croniger CM, Millward C, Yang J, Kawai Y, Arinze IJ, Liu S, Harada-Shiba M, Chakravarty K, Friedman JE, Poli V, Hanson RW. Mice with a deletion in the gene for CCAAT/enhancer-binding protein beta have an attenuated response to cAMP and impaired carbohydrate metabolism. J Biol Chem. 2001 Jan 05; 276(1):629-38.
-
Oliveira CM, Banerjee DK. Role of extracellular signaling on endothelial cell proliferation and protein N-glycosylation. J Cell Physiol. 1990 Sep; 144(3):467-72.
-
Izzo JL, Roncone AM, Kleiman F. Subcellular distribution of 125I-insulin by rat liver: specificity and regulatory factors. Am J Physiol. 1983 Mar; 244(3):E272-81.
-
Kawai Y, Arinze IJ. Activation of glycogenolysis in neonatal liver. J Biol Chem. 1981 Jan 25; 256(2):853-8.
-
Van Woert MH, Mueller PS, Ambani LM, Rathey U. Abnormal insulin secretion in Parkinson's disease before and during L-dihydroxyphenylalanine (L-dopa) therapy. J Endocrinol. 1973 Dec; 59(3):523-34.